Search

Your search keyword '"Azenkot T"' showing total 16 results

Search Constraints

Start Over You searched for: Author "Azenkot T" Remove constraint Author: "Azenkot T"
16 results on '"Azenkot T"'

Search Results

2. Measurable residual disease conversion rate with consolidation chemotherapy in acute myeloid leukemia.

4. Outcomes with molecularly targeted agents as salvage therapy following frontline venetoclax + hypomethylating agent in adults with acute myeloid leukemia: A multicenter retrospective analysis.

5. Tobacco and Cannabis Use During and After Pregnancy in California.

7. Hospital-acquired influenza in the United States, FluSurv-NET, 2011-2012 through 2018-2019.

8. Special Considerations for Women of Reproductive Age on Anticoagulation.

9. Clinical experience with frontline Hyper-CVAD-based regimens, including Hyper-CVAD plus ponatinib, in patients with acute lymphoblastic leukemia treated at a comprehensive cancer center.

10. Clinical Impact of Measurable Residual Disease in Acute Myeloid Leukemia.

11. Outcomes of allogeneic transplantation after hypomethylating agents with venetoclax in acute myeloid leukemia.

12. Venetoclax-based combinations for the treatment of newly diagnosed acute myeloid leukemia.

13. An evaluation of venetoclax in combination with azacitidine, decitabine, or low-dose cytarabine as therapy for acute myeloid leukemia.

14. Cytomegalovirus shedding from breastmilk and mucosal sites in healthy postpartum women: A pilot study.

15. BCG vaccination induces HIV target cell activation in HIV-exposed infants in a randomized trial.

16. Sugar-induced cephalic-phase insulin release is mediated by a T1r2+T1r3-independent taste transduction pathway in mice.

Catalog

Books, media, physical & digital resources